You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
药明康德(603259.SH)拟发行3亿美元2024年到期零息可转债
格隆汇 09-04 08:47

格隆汇9月4日丨药明康德(603259.SH)宣布,2019年9月3日,公司与联席牵头经办人高盛(亚洲)、华泰金融控股(香港)、J.P. Morgan Securities plc及Morgan Stanley & Co. International plc及副经办人浦银国际融资签署认购协议,根据该协议,在达成该协议所述条件的前提下,公司同意发行,且联席牵头经办人及副经办人分别而非连带地同意认购和支付(或促使认购人认购和支付)3亿美元2024年到期零息可转换债券。

债券初步转换价为每股(H股)111.80港元,较2019年9月3日在联交所所报最后收盘价每股(H股)86.00港元溢价约30.00%。假设按初步转换价每股(H股)111.80港元全部转换为债券,则债券将转换为约2104.8032万股H股,占公司现有已发行H股股本约12.34%,及占经扩大后总H股股本约10.99%。

此次发行的募集资金总额将为3亿美元,公司拟将所得款项用于并购;业务扩张;及营运资金及一般公司用途。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account